Sultosilic acid (BioDeep_00000655808)

   


代谢物信息卡片


2-hydroxy-5-(4-methylphenyl)sulfonyloxybenzenesulfonic acid

化学式: C13H12O7S2 (344.00244419999996)
中文名称: 磺托酸
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1=CC=C(C=C1)S(=O)(=O)OC2=CC(=C(C=C2)O)S(=O)(=O)O
InChI: InChI=1S/C13H12O7S2/c1-9-2-5-11(6-3-9)22(18,19)20-10-4-7-12(14)13(8-10)21(15,16)17/h2-8,14H,1H3,(H,15,16,17)

描述信息

C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent

同义名列表

2 个代谢物同义名

2-hydroxy-5-(4-methylphenyl)sulfonyloxybenzenesulfonic acid; Sultosilic acid



数据库引用编号

5 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Benjamin J Ansell. Rationale for combination therapy with statin drugs in the treatment of dyslipidemia. Current atherosclerosis reports. 2005 Feb; 7(1):29-33. doi: 10.1007/s11883-005-0072-7. [PMID: 15683599]
  • Lluís Masana, Jesús Villoria, Mariano Sust, Emilio Ros, Nuria Plana, Francisco Pérez-Jiménez, Miguel Franco, Josefina J Oliván, Xavier Pintó, Sebastián Videla. Treatment of type IIb familial combined hyperlipidemia with the combination pravastatin-piperazine sultosilate. European journal of pharmacology. 2004 Aug; 496(1-3):205-12. doi: 10.1016/j.ejphar.2004.05.041. [PMID: 15288592]
  • R Roser, L Martinez, S Pares, R Sagarra, J Esteve. Single and multiple dose pharmacokinetics of sultosilic acid in humans. European journal of drug metabolism and pharmacokinetics. 1986 Jan; 11(1):1-7. doi: 10.1007/bf03189768. [PMID: 3720792]
  • H Vinazzer, J C Farine. Double-blind cross-over study of the effect of sultosilic acid piperazine salt (A-585) and bezafibrate in primary hyperlipoproteinemia. Atherosclerosis. 1983 Nov; 49(2):109-18. doi: 10.1016/0021-9150(83)90188-0. [PMID: 6686778]
  • S G Wood, D Kirkpatrick, A J Jackson, D R Hawkins, W H Down, L F Chasseaud, S R Biggs, A Darragh. The metabolism of the hypolipidaemic drug sultosilic acid in rat, dog and man. Xenobiotica; the fate of foreign compounds in biological systems. 1982 Mar; 12(3):165-76. doi: 10.3109/00498258209046791. [PMID: 7113253]
  • L Giuliani, G Carmignani, E Belgrano, P Puppo. Transcatheter arterial embolization in urological tumors: the use of isobutyl-2-cyanoacrylate. The Journal of urology. 1979 May; 121(5):630-4. doi: 10.1016/s0022-5347(17)56913-x. [PMID: 439260]
  • M E Mayo, W H Chapman, D B Shurtleff. Bladder function in children with meningomyelocele: comparison of cine-fluoroscopy and urodynamics. The Journal of urology. 1979 Apr; 121(4):458-61. doi: 10.1016/s0022-5347(17)56823-8. [PMID: 439218]
  • H J Hilderson, M J De Wolf, A R Lagrou, W S Dierick. Subcellular structure of bovine thyroid gland. A study on bovine thyroid membranes by buoyant-density-gradient centrifugation in a B-XIV zonal rotor. The Biochemical journal. 1975 Dec; 152(3):601-7. doi: 10.1042/bj1520601. [PMID: 5997]